Article
Early clinical experience of bacteriophage therapy in 3 lung transplant recipients
17 Jun 2019
Abstract excerpt
Bacteriophage therapy (BT) uses bacteriophages to treat pathogenic bacteria and is an emerging strategy against multidrug-resistant (MDR) infections. Experience in solid organ transplant is limited. We describe BT in 3 lung transplant recipients (LTR) with life-threatening MDR infections caused by Pseudomonas aeruginosa (n = 2) and Burkholderia dolosa (n = 1). For each patient, lytic bacteriophages were selected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
